e-learning
resources
Vienna 2012
Monday, 03.09.2012
Lung function tests in monitoring airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heterogeneity of small airways flow and hyperinflation are markers of a persistent obstruction phenotype in severe non-controlled asthmatics
R.M. Carvalho-Pinto, A. Cukier, L. Angelini, F.L.A. Fernandes, J.M. Salge, R. Stelmach (Sao Paulo, Brazil)
Source:
Annual Congress 2012 - Lung function tests in monitoring airway diseases
Session:
Lung function tests in monitoring airway diseases
Session type:
Thematic Poster Session
Number:
2255
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R.M. Carvalho-Pinto, A. Cukier, L. Angelini, F.L.A. Fernandes, J.M. Salge, R. Stelmach (Sao Paulo, Brazil). Heterogeneity of small airways flow and hyperinflation are markers of a persistent obstruction phenotype in severe non-controlled asthmatics. Eur Respir J 2012; 40: Suppl. 56, 2255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004
Phenotypic characteristics of asthmatic patients with small airways obstruction
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Airway remodeling in severe asthmatics with fixed or variable airflow obstruction
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007
Between-visit variability of small airway obstruction markers in patients with asthma
Source: Eur Respir J 2014; 44: 242-244
Year: 2014
Significance of persistent airflow obstruction in patients with severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002
Small airway impairment in severe asthmatic patients
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
Predictors of exercise-induced airways obstruction in patients with mild asthma.
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020
The reversibility of bronchial obstruction and hyperinflation at COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
Proximal and peripheral airway morphologic changes in elderly patients with asthma with fixed airflow obstruction and COPD
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Markers of difference of severe bronchial asthma and chronic obstructive diseases of lungs with irreversible obstruction
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 174s
Year: 2001
Fixed airway obstruction in patients with severe asthma
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Contribution of airway dimensions to severity of blood gas disturbances in patients with chronic airflow obstruction
Source: Annual Congress 2009 - New data on respiratory function - from experimental approaches to man
Year: 2009
Ematic gases,bronchial obstruction and RV increase in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 328s
Year: 2004
The role of small airways in obstructive airway diseases
Source: Eur Respir Rev 2011; 20: 23-33
Year: 2011
Phenotypic characteristics of asthmatic patients with distal airways obstruction
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept